Renfeng Guo

3.6k total citations
42 papers, 2.6k citations indexed

About

Renfeng Guo is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Renfeng Guo has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 12 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Renfeng Guo's work include Complement system in diseases (17 papers), Immune Response and Inflammation (12 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Renfeng Guo is often cited by papers focused on Complement system in diseases (17 papers), Immune Response and Inflammation (12 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Renfeng Guo collaborates with scholars based in United States, China and Germany. Renfeng Guo's co-authors include Peter A. Ward, Niels C. Riedemann, Firas S. Zetoune, Thomas A. Neff, Vidya Sarma, Renxi Wang, Bing Shen, J. Vidya Sarma, Ellen M. Younkin and Ines J. Laudes and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Renfeng Guo

40 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renfeng Guo United States 28 1.5k 599 584 429 260 42 2.6k
Anton T. J. Tool Netherlands 30 1.5k 1.0× 650 1.1× 468 0.8× 427 1.0× 266 1.0× 67 2.9k
Markus Bosmann United States 29 1.4k 0.9× 806 1.3× 604 1.0× 275 0.6× 271 1.0× 67 2.6k
Guozheng Wang United Kingdom 31 1.0k 0.7× 1.3k 2.2× 547 0.9× 194 0.5× 299 1.1× 81 2.9k
Juergen Lohmeyer Germany 18 1.8k 1.2× 815 1.4× 687 1.2× 278 0.6× 781 3.0× 27 2.9k
Kindra M. Kelly‐Scumpia United States 21 1.6k 1.0× 417 0.7× 632 1.1× 302 0.7× 207 0.8× 30 2.3k
Alexandre Pachot France 29 1.5k 1.0× 615 1.0× 1.3k 2.3× 294 0.7× 188 0.7× 67 2.9k
Christophe Paget France 31 2.3k 1.5× 554 0.9× 468 0.8× 284 0.7× 180 0.7× 64 3.2k
Panagiotis Skendros Greece 27 2.0k 1.3× 1.1k 1.8× 477 0.8× 522 1.2× 450 1.7× 70 3.2k
Jean Parodo Canada 20 922 0.6× 752 1.3× 800 1.4× 109 0.3× 205 0.8× 30 2.2k
H. Gallati Switzerland 30 1.1k 0.7× 380 0.6× 730 1.3× 249 0.6× 260 1.0× 53 2.7k

Countries citing papers authored by Renfeng Guo

Since Specialization
Citations

This map shows the geographic impact of Renfeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renfeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renfeng Guo more than expected).

Fields of papers citing papers by Renfeng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renfeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renfeng Guo. The network helps show where Renfeng Guo may publish in the future.

Co-authorship network of co-authors of Renfeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Renfeng Guo. A scholar is included among the top collaborators of Renfeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renfeng Guo. Renfeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chemaly, Roy F., Alexander P. J. Vlaar, Endry H. T. Lim, et al.. (2025). 85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Vlaar, Alexander P. J., Endry H. T. Lim, Sanne de Bruin, et al.. (2022). The anti‐C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID‐19. Clinical and Translational Science. 15(4). 854–858. 16 indexed citations
3.
Wang, Zhihong, Longlong Luo, Yu Chen, et al.. (2019). Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage. Mucosal Immunology. 12(5). 1164–1173. 44 indexed citations
4.
Riedemann, Niels C., et al.. (2017). Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition. Clinical Immunology. 180. 25–32. 34 indexed citations
5.
Pan, Xiujie, Zhihua Yang, Renfeng Guo, et al.. (2015). Regulatory T Cells Promote β-Catenin–Mediated Epithelium-to-Mesenchyme Transition During Radiation-Induced Pulmonary Fibrosis. International Journal of Radiation Oncology*Biology*Physics. 93(2). 425–435. 50 indexed citations
6.
7.
Schmal, Hagen, et al.. (2014). Early Intra-Articular Complement Activation in Ankle Fractures. BioMed Research International. 2014. 1–8. 18 indexed citations
8.
Wang, Yi, Gencheng Han, Ke Wang, et al.. (2013). Tumor-Derived GM-CSF Promotes Inflammatory Colon Carcinogenesis via Stimulating Epithelial Release of VEGF. Cancer Research. 74(3). 716–726. 52 indexed citations
9.
Sun, Shihui, Guangyu Zhao, Chenfeng Liu, et al.. (2013). Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection. American Journal of Respiratory Cell and Molecular Biology. 49(2). 221–230. 90 indexed citations
10.
Wang, Ke, Gencheng Han, Yi Wang, et al.. (2012). Opposite Role of Tumor Necrosis Factor Receptors in Dextran Sulfate Sodium-Induced Colitis in Mice. PLoS ONE. 7(12). e52924–e52924. 32 indexed citations
11.
Zhou, Lin, Jiannan Feng, Renfeng Guo, et al.. (2011). Identification of conformational core epitope Lys68 in C5a based on the 3-D modeling complex C5a and its functional antibody F20. Molecular Immunology. 48(12-13). 1377–1383.
12.
Wang, Liyan, Gencheng Han, Renxi Wang, et al.. (2010). Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis. Clinical Immunology. 137(1). 157–165. 27 indexed citations
13.
Chen, Guojiang, Yuemei Yang, Xudong Gao, et al.. (2010). Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis. Laboratory Investigation. 91(3). 472–483. 36 indexed citations
14.
Wrann, Christiane D., Tanja Barkhausen, Andreas Klos, et al.. (2007). The Phosphatidylinositol 3-Kinase Signaling Pathway Exerts Protective Effects during Sepsis by Controlling C5a-Mediated Activation of Innate Immune Functions. The Journal of Immunology. 178(9). 5940–5948. 48 indexed citations
15.
Gao, Hongwei, Renfeng Guo, Cecilia L. Speyer, et al.. (2004). Stat3 Activation in Acute Lung Injury. The Journal of Immunology. 172(12). 7703–7712. 87 indexed citations
16.
Riedemann, Niels C., Renfeng Guo, Thomas A. Neff, et al.. (2002). Increased C5a receptor expression in sepsis. Journal of Clinical Investigation. 110(1). 101–108. 18 indexed citations
17.
Jordan, Jacqueline A., Renfeng Guo, Vidya Sarma, et al.. (2001). Role of IL-18 in Acute Lung Inflammation. The Journal of Immunology. 167(12). 7060–7068. 86 indexed citations
18.
Guo, Renfeng, Alex B. Lentsch, Roscoe L. Warner, et al.. (2001). Regulatory Effects of Eotaxin on Acute Lung Inflammatory Injury. The Journal of Immunology. 166(8). 5208–5218. 20 indexed citations
19.
Huber‐Lang, Markus, Vidya Sarma, Kristina T. Lu, et al.. (2001). Role of C5a in Multiorgan Failure During Sepsis. The Journal of Immunology. 166(2). 1193–1199. 188 indexed citations
20.
Warner, Roscoe L., Nicolas M. Bless, Ellen M. Younkin, et al.. (2000). Time-dependent inhibition of immune complex-induced lung injury by catalase: relationship to alterations in macrophage and neutrophil matrix metalloproteinase elaboration. Free Radical Biology and Medicine. 29(1). 8–16. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton T. J. Tool Breakdown of academic impact, for papers by Markus Bosmann Breakdown of academic impact, for papers by Guozheng Wang Breakdown of academic impact, for papers by Juergen Lohmeyer Breakdown of academic impact, for papers by Kindra M. Kelly‐Scumpia Breakdown of academic impact, for papers by Alexandre Pachot Breakdown of academic impact, for papers by Christophe Paget Breakdown of academic impact, for papers by Panagiotis Skendros Breakdown of academic impact, for papers by Jean Parodo Breakdown of academic impact, for papers by H. Gallati
Rankless by CCL
2026